id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
DEA-2012-0007-0074,DEA,DEA-2012-0007,Schedules of Controlled Substances: Placement of Lorcaserin into Schedule IV,Rule,,2013-05-08T04:00:00Z,2013,5,2013-05-08T04:00:00Z,,2015-11-17T16:55:33Z,2013-10895,0,0,09000064812c45f0
DEA-2012-0007-0073,DEA,DEA-2012-0007,Lorcaserin HHS Scientific and Medical Evaluation and Scheduling Recommendation (Redacted),Supporting & Related Material,,2013-04-17T04:00:00Z,2013,4,,,2013-04-17T15:19:02Z,,0,0,09000064812970b9
DEA-2012-0007-0002,DEA,DEA-2012-0007,"DEA Lorcaserin Background, Data, and Analysis Document",Supporting & Related Material,,2012-12-21T05:00:00Z,2012,12,,,2012-12-21T14:16:25Z,,0,0,09000064811953df
DEA-2012-0007-0007,DEA,DEA-2012-0007,HHS Lorcaserin Scientific and Medical Evaluation and Scheduling Recommendation,Supporting & Related Material,,2012-12-21T00:00:00Z,2012,12,,,2013-04-17T15:12:13Z,,0,1,0900006481195eb0
DEA-2012-0007-0001,DEA,DEA-2012-0007,Schedules of Controlled Substances: Placement of Lorcaserin into Schedule IV,Proposed Rule,,2012-12-19T05:00:00Z,2012,12,2012-12-19T05:00:00Z,2013-01-19T04:59:59Z,2014-01-18T19:53:24Z,2012-30531,0,0,0900006481192372